James Peyer
Director/Board Member at SENSEI BIOTHERAPEUTICS, INC.
James Peyer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Director/Board Member | 01/01/2020 | - |
| Independent Dir/Board Member | 01/01/2020 | - | |
Cambrian BioPharma, Inc.
 Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | Director/Board Member | 01/01/2019 | - |
| Chief Executive Officer | 01/01/2019 | - | |
| Founder | 01/01/2019 | - | |
Isterian Biotech, Inc.
 Isterian Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Isterian Biotech, Inc. engages in the business of biotechnology services. The company is headquartered in Brooklyn, NY. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| President | - | - | |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Part of Cambrian BioPharma, Inc., Amplifier TX AB is a Swedish biopharmaceutical company that develops clinical molecule AMPK activators. The private company is based in Umeå, Sweden. The company was founded in 2023 by Thomas Edlund, Helena Edlund. James Hall has been the CEO of the company since 2023. | Chairman | - | - |
Career history of James Peyer
Former positions of James Peyer
| Companies | Position | Start | End |
|---|---|---|---|
Aeovian Pharmaceuticals, Inc.
 Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Director/Board Member | 01/06/2017 | 01/06/2019 |
Cleara Biotech BV
 Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Director/Board Member | 01/02/2018 | 01/06/2019 |
| Founder | 01/02/2018 | 01/06/2019 | |
Samsara Therapeutics, Inc.
 Samsara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Samsara Therapeutics, Inc. operates as a biopharmaceutical platform company. It engages in the development and commercialization of first-in-class therapeutics for the treatment of unmet medical needs and age-related diseases. The company was founded by Sebastian Aguiar in 2018 and is headquartered in Lewes, DE. | Director/Board Member | 01/03/2018 | 01/06/2019 |
Apollo Ventures Holding GmbH
 Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg. | Founder | 01/01/2016 | 01/01/2019 |
| Corporate Officer/Principal | 01/01/2016 | 01/01/2019 |
Training of James Peyer
| The University of Chicago | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Statistics
International
| United States | 8 |
| Germany | 2 |
| Netherlands | 2 |
Operational
| Director/Board Member | 6 |
| Founder | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | Health Technology |
Isterian Biotech, Inc.
Isterian Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Isterian Biotech, Inc. engages in the business of biotechnology services. The company is headquartered in Brooklyn, NY. | Commercial Services |
Apollo Ventures Holding GmbH
Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg. | Finance |
Cleara Biotech BV
Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Health Technology |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Health Technology |
Samsara Therapeutics, Inc.
Samsara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Samsara Therapeutics, Inc. operates as a biopharmaceutical platform company. It engages in the development and commercialization of first-in-class therapeutics for the treatment of unmet medical needs and age-related diseases. The company was founded by Sebastian Aguiar in 2018 and is headquartered in Lewes, DE. | Health Technology |
Amplifier TX AB
Amplifier TX AB BiotechnologyHealth Technology Part of Cambrian BioPharma, Inc., Amplifier TX AB is a Swedish biopharmaceutical company that develops clinical molecule AMPK activators. The private company is based in Umeå, Sweden. The company was founded in 2023 by Thomas Edlund, Helena Edlund. James Hall has been the CEO of the company since 2023. | Health Technology |
- Stock Market
- Insiders
- James Peyer
- Experience
